Lee Young Ju, Mubasher Mahmood, Zainal Abir, Syed Tausif, Mohamed Mouhand F H, Ferrantino Matthew, Hoefen Ryan
Unity Hospital, Rochester Regional Health, Rochester, New York, USA.
Internal Medicine Department, Hamad Medical Corporation, Doha, Qatar.
Clin Med Insights Case Rep. 2020 Oct 30;13:1179547620965559. doi: 10.1177/1179547620965559. eCollection 2020.
Post-cardiac injury syndrome (PCIS) is presumed to be an immune-mediated process. It affects the pericardium and, to a lesser extent, the epicardium, myocardium, and pleura. It has been rarely reported following pacemaker insertion with an estimated incidence of 1% to 2%. We present the case of a 62-year-old female who developed PCIS 8 weeks following pacemaker insertion. She presented with impending cardiac tamponade requiring pericardiocentesis; recurrent pleural effusions subsequently complicated her condition. The pleural effusion recurred despite trials of steroids, eventually requiring talc pleurodesis. This case highlights the need to consider PCIS as a possible etiology of recurrent pleural effusion following pacemaker insertion.
心脏损伤后综合征(PCIS)被认为是一种免疫介导的过程。它会影响心包,在较小程度上也会影响心外膜、心肌和胸膜。起搏器植入术后很少有该综合征的报道,估计发病率为1%至2%。我们报告一例62岁女性患者,在起搏器植入术后8周发生了PCIS。她出现了即将发生心脏压塞的症状,需要进行心包穿刺;随后反复出现胸腔积液使她的病情复杂化。尽管试用了类固醇药物,胸腔积液仍反复出现,最终需要进行滑石粉胸膜固定术。该病例强调了需要将PCIS视为起搏器植入术后反复胸腔积液的一种可能病因。